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Abstract
Background: Given the immuno-modulatory activity of native haemozoin (Hz), the effects of
constitutive Hz components on immune response are of interest. Recently, gene expression
changes mediated by HNE and the synthetic analogue of Hz, beta-haematin (BH), were identified
and implicated a significant role for lipid peroxidation products in Hz's activity. The study presented
herein examines gene expression changes in response to 15(S)-hydroxyeicosatetraenoic acid
(HETE) in a model macrophage cell line.
Methods: LPS-stimulated RAW 264.7 macrophage-like cells were treated with 40 μM 15(S)-HETE
for 24 h, and microarray analysis was used to identify global gene expression alterations. Fold
changes were calculated relative to LPS-stimulated cells and those genes altered at least 1.8-fold (p
value ≤ 0.025) were considered to be differentially expressed. Expression levels of a subset of genes
were assessed by qRT-PCR and used to confirm the microarray results.
Results:  Network analysis revealed that altered genes were primarily associated with "lipid
metabolism" and "small molecule biochemistry". While several genes associated with PPAR-gamma
receptor-mediated signaling were differentially expressed, a number of genes indicated the
activation of secondary signaling cascades. Genes related to cytoadherence (cell-cell and cell-
matrix), leukocyte extravasation, and inflammatory response were also differentially regulated by
treatment, supporting a potential role for 15(S)-HETE in malaria pathogenesis.
Conclusion: These results add insight and detail to 15-HETE's effects on gene expression in
macrophage-like cells. Data indicate that while 15-HETE exerts biological activity and may
participate in Hz-mediated immuno-modulation, the gene expression changes are modest relative
to those altered by the lipid peroxidation product HNE.
Background
Although haem is a vital cofactor for a diverse set of pro-
teins involved in respiration, oxygen transport, and drug
detoxification, the accumulation of free haem has delete-
rious effects. Haem is capable of binding to lipid bilayers,
catalyzing lipid peroxidation, inhibiting enzymatic activ-
ity, and lysing cells and parasites [1,2]. Many organisms
utilize the haem oxygenase pathway to degrade free haem.
Blood-feeding Plasmodium parasites, the source of malaria
infection, lack such a pathway. Consequently, haem
Published: 11 August 2009
Malaria Journal 2009, 8:195 doi:10.1186/1475-2875-8-195
Received: 26 March 2009
Accepted: 11 August 2009
This article is available from: http://www.malariajournal.com/content/8/1/195
© 2009 Schrimpe and Wright; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
Page 2 of 12
(page number not for citation purposes)
released during haemoglobin catabolism is sequestered as
the insoluble crystalline "malaria pigment" (i.e., haemo-
zoin [Hz]). As most of the haem is occluded within the
crystal, the parasite is protected.
Hz is composed of five-coordinate Fe (III) protoporphyrin
IX dimers covalently bound by reciprocal iron-carboxylate
bonds [3]. The remaining propionate side chains of adja-
cent dimers form hydrogen bonds, resulting in an
extended dimeric network producing the Hz crystal. In its
native state, Hz is coated by an array of host- and parasite-
derived lipids, proteins, and nucleic acids [4]. Analysis of
the lipid component identified peroxidation products
including a racemic mixture of 5-, 8-, 9-, 11-, 12-, and 15-
hydroxyeicosatetraenoic acids (HETEs) and 9- and 13-
hydroxyoctadecadienoic acids (HODEs) [5]. Elevated lev-
els of 4-hydroxynonenal (HNE) were also detected in
haemozoin-laden monocytes [6] at the highest reported
concentration of any biological system to date [7].
Rupture of parasitized red blood cells (RBCs) releases cel-
lular debris, including residual bodies containing Hz, into
the host's vasculature and triggers an innate immune
response. The typical response of phagocytic cells to such
foreign material includes oxidative burst and rephagocy-
tosis, however, phagocytosis of Hz impairs these innate
functions [8-10]. It has been suggested that Hz's immuno-
logical activity may not stem from the haem moiety but
from nonspecific toxins [11], such as lipid peroxidation
products, present on its surface and introduced into the
cell during phagocytosis
The cellular response to several lipid peroxidation species
associated with Hz is well documented and indicates an
involvement in malaria pathophysiology. Recently, two
components of native Hz were targeted as potential play-
ers involved in macrophage dysfunction [12]. Microarray
analysis of the response to HNE and Hz's biologically
naïve synthetic analogue, β-haematin (BH), indicated a
potential role for HNE in malaria pathogenesis. It seemed
probable, given HNE-mediated gene expression changes,
that other biologically active lipid peroxidation products
generated by Hz, including 15-HETE, may be active in the
disease's pathogenesis.
Macrophage-like cells treated with 15-HETE exhibited
impaired PMA-activated NADPH oxidase and LPS-stimu-
lated inducible nitric oxide synthase (iNOS) activities,
mimicking Hz-mediated monocyte immunomodulation
[13]. 15-HETE was also reported to enhance vascular per-
meability/oedema [14] and RBC adherence to endothelia
[15], two hallmarks of malarial infection. The present
study examined steady-state gene expression changes
induced by 15-HETE in activated RAW 264.7 model mac-
rophage cells in the context of a nonspecific malaria toxin
that may be involved in disease pathophysiology.
Methods
Cell culture
Murine macrophage-like RAW 264.7 cells (American Type
Culture Collection TIB-71, Monassas, VA) were cultured
under standard incubation conditions (37°C, 5% CO2)
and grown in RPMI supplemented with 10% FBS (Atlanta
Biologicals, Atlanta, GA) and 1 μg/mL P/S (Cellgro Medi-
aTech, Herndon, VA). Cells were plated at a density of 4 ×
106 cells/well in six well plates and incubated for 24 h
prior to treatment.
Cell treatment and RNA isolation
Cells were washed once with Dulbecco's PBS (DPBS) and
treated with 40 μM 15(S)-HETE. Immediately following
treatment, LPS was added to all wells at a final concentra-
tion of 1 μg/mL. After 24 h, cells were washed three times
with DPBS and scraped from the wells. Three biological
replicates (composed of six pooled wells each) per sample
were prepared. Total RNA was isolated using the Versa-
gene RNA purification and DNase treatment kits, follow-
ing the manufacturer's recommendations.
Microarray analysis
Microarray analysis was performed by the Vanderbilt
Microarray Shared Resource. Three biological replicates of
each treatment were analyzed for quality (Agilent 2100
Bioanalyzer, Agilent Technologies, Palo Alto, CA). One
microgram of total RNA (30 ng mRNA) was used to gen-
erate first strand cDNA using the NanoAmp RT-IVT labe-
ling kit according to the manufacturer's protocol.
Following first strand synthesis, second strand synthesis
was completed. The resulting cDNA was then purified
using an ABI kit-provided column and the entire reaction
was used in an IVT reaction to generate DIG-labeled
cRNA. The cRNA was then purified using a kit-provided
column and assessed for quality on an Agilent Bioana-
lyzer. All reactions meeting ABI criteria in terms of quan-
tity and size of target produced were fragmented and then
hybridized to an ABI mouse genome survey microarray
for 16 h with agitation at 55°C per the manufacturer's
protocol. Following the addition of the chemilumines-
cence reaction substrate, each array was immediately
imaged on the 1700 Chemiluminescent Analyzer, and a
primary analysis was completed by the AB1700 Expres-
sion Array System Software (v 1.1.1). Expression values
were quantile normalized and filtered based on S/N (> 3)
and flag value (< 5000). GeneSpring GX 7.3.1 software
(Agilent Silicon Genetics, Redwood City, CA) was used to
determine statistically significant differentially expressed
genes. T-tests were performed on probes altered by ≥ 1.8-
fold in 2 of 3 samples (0.025 p value cut-off, Benjamini-Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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Hochberg multiple testing correction, parametric test, var-
iances not assumed equal) in treated stimulated cells
(experimental) relative to stimulated cells (control).
Genes were classified according to genes ontology (GO)
terms using GeneSpring. In accordance with MIAME pro-
cedure, microarray data have been submitted to the NCBI
Gene Expression Omnibus and can be found under series
number GSE15070. Nomenclature for genes and proteins
is as described by the Mouse Genome Informatics (MGI)
database guidelines.
Ingenuity pathway analysis
Ingenuity Pathways Analysis (IPA) was used for gene
expression analysis (Ingenuity Systems®). A data set con-
taining gene identifiers and corresponding expression val-
ues was uploaded into the application, and each identifier
was mapped to its corresponding gene object in the Inge-
nuity knowledge base (IKB). A functional analysis was
performed to determine biological functions that were
most significant to the genes in the data set. A network
analysis was also performed whereby focus genes were
overlaid onto a global molecular network developed from
information contained in the IKB. Networks of focus
genes were then algorithmically generated based on their
connectivity. A functional analysis of each network iden-
tified the biological functions that were most significant
to the genes in the network, and canonical pathway anal-
ysis identified the pathways from the IPA library of canon-
ical pathways that were most significant to the data set.
Fischer's exact test was used to calculate a p value deter-
mining the probability that that each biological function
assigned to a network or data set, or the association
between the genes in the data set and the canonical path-
way, are explained by chance alone.
Real-time reverse transcription polymerase chain reaction
Quantitative real-time reverse transcription polymerase
chain reaction (qRT-PCR) was used to validate the expres-
sion levels of genes identified as differentially expressed
by microarray analysis. Quadruplicate measurements for
n = 3 independent biological replicates per sample were
performed. cDNA was reverse-transcribed from 0.5 μg of
total RNA using random hexamer primers and Superscript
II Reverse Transcriptase (Invitrogen). Reactions were puri-
fied using Qiagen's PCR Purification Kit following the
manufacturer's protocol. Following RT, all assays were
performed with Applied Biosystems TaqMan FAM labeled
20× probes: Arf3  (Taqman assay Mm00500194_m1),
Cldn11  (Mm00500915_m1),  Cxcl11
(Mm00444662_m1),  Mapk14  (Mm00442497_m1),
Prdx1  (Mm01621996_s1),  Sdc1  (Mm00448918_m1),
and Egr1 (Mm00656724_m1). Ywhaz was chosen as the
endogenous control based on results obtained from an
Applied Biosystems mouse endogenous control array.
cDNA amplification was performed using TaqMan 2×
Universal PCR Master Mix (Applied Biosystems), and
standard Taqman cycling conditions were used as speci-
fied by the manufacturer. Cycling and data collection were
performed using the Applied Biosystems 7900 HT instru-
ment, and analysis was performed using SDS software to
calculate Ct values for each detector. Ct values were proc-
essed based on the comparative Ct method where the rel-
ative transcript level of each target gene was calculated
according to the equation 2-ΔCt, where ΔCt is defined as Ct
target gene – Ct Ywhaz.
Results
Functional analysis of gene expression changes induced by 
15(S)-HETE
LPS-stimulated macrophage-like RAW 264.7 cells were
treated for 24 h with 40 μM 15(S)-HETE based on the esti-
mate that trophozoites and Hz contained 33–39 μmol 15-
HETE/L RBC [5]. Statistically significant (p  ≤ 0.025)
changes in gene expression (fold change ≥ 1.8 relative to
stimulated cells) were identified by microarray analysis.
Given that this study aims to explore potential alterations
in gene expression that are incurred by 15-HETE during
haemozoin phagocytosis, differentially expressed mRNAs
were controlled by comparison with a particulate latex
bead challenge and BH treatment under the same condi-
tions. Figure 1 illustrates that 15-HETE had a much greater
effect on induction of gene expression than repression
(293 transcripts versus 100 transcripts, respectively), but
overall was very modest compared to either latex bead or
BH treatment.
Comparison of differentially expressed genes mediated by  15-HETE, beta-haematin, and latex beads Figure 1
Comparison of differentially expressed genes medi-
ated by 15-HETE, beta-haematin, and latex beads. 
Venn diagrams show the intersection of genes that were 
transcriptionally altered by 40 μM 15-HETE with those 
altered by latex bead treatment and serum-opsonized beta 
haematin (BH) (0.1 mg/mL). Numbers represent statistically 
significant (p ≤ 0.025) transcripts up- or down-regulated ≥ 
1.8-fold in 2 of 3 samples, relative to LPS-stimulated 
untreated cells at 24 h. (A) Decreased and (B) increased 
expression are shown separately.Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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Ingenuity Pathway Analysis (IPA) software was used to
examine biological relationships associated with 15-
HETE-mediated expression changes. Identifiers and rela-
tive levels of altered genes comprising the data set were
imported and mapped by IPA for comparison to mole-
cules within the Ingenuity knowledge base (IKB). Two
types of IPA analyses were performed. First, a network
analysis was employed to reveal direct and indirect rela-
tionships that exist between specific genes in the data set.
This analysis resulted in the generation of a network map
which illustrates direct and indirect connections between
focus genes. Second, a functional analysis was performed
to identify the biological processes that are most relevant
to the entire set of differentially expressed genes. This
analysis resulted in a list of significant biological func-
tions associated with the data set as a whole. Functional
analyses were also used to find biological processes asso-
ciated with individual networks. Focus genes, imported
genes that are eligible for generating interaction networks
based on incorporation in IKB, were used to identify rela-
tionships based on known interactions in the literature.
Each network is associated with a score indicating the like-
lihood that the focus genes occur in the network by ran-
dom chance. Networks scoring 10 or higher (score is
defined as -log (p value)) are considered significant.
Among the transcripts modulated by 15-HETE treatment,
263 were eligible for network analysis based on IPA crite-
ria, mapping to 11 relevant interaction networks. The
most significant network (Figure 2a) had a score of 51 and
associated 27 focus genes. Several transcriptional regula-
tors were among the products encoded by these genes
(Bclaf1, Med1, Noc2l, Rnf4, and Zfp36l1). This network
also contained Il1b, Cyp3a4, Gnas, and Adfp. A functional
analysis performed on this particular network indicated
that the differentially expressed genes were associated
with "lipid metabolism" and "small molecule biochemis-
try" (p = 1.27 × 10-4).
Figure 2b shows the second most significant interaction
network identified by IPA network analysis. Eighteen
focus genes were incorporated into the network with a
score of 29. Functional analysis of the network revealed
that the genes were involved in "molecular transport" (p
= 9.42 × 10-7) and "cellular movement" (p = 9.77 × 10-6).
This network is enriched with focus genes encoding mol-
ecules associated with the plasma membrane such as
Pkd2, Cd300a, Cldn11, Gypc, Klra4, peptidase Adam9 and
transporters  Atp1a2,  Slc16a1, and Slc16a3. Consistent
with these genes, the network predicted interactions with
several other plasma membrane molecules (Tjp2,  Bsg,
Ingenuity Pathway network analysis Figure 2
Ingenuity Pathway network analysis. Transcripts altered ≥ 1.8-fold (p ≤ 0.025) in 15-HETE-treated RAW 264.7 cells (i.e., 
focus genes) were overlaid onto a global molecular network developed from information contained in the Ingenuity knowledge 
base (IKB). Networks of these focus genes were algorithmically generated based on their connectivity. Networks show direct 
interactions between focus genes altered by 15-HETE treatment and associated molecules within the IKB. Genes or gene prod-
ucts are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). White 
nodes represent IKB molecules that are associated with focus genes. All edges are supported by at least one reference stored 
in the IKB. The intensity of node color indicates the degree of up- (red) or down- (green) regulation. Networks reflect (A) lipid 
metabolism and small molecule biochemistry and (B) molecular transport and cellular movement.Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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Cdh1, Tspan3, Tspan4, Cd247, Itgb1, and Atp1b2) that were
not present in the data file.
Molecular and cellular functions controlled by 15(S)-HETE
It is thought that Hz impairs cellular function through the
generation and introduction of toxic species such as lipid
peroxidation products into cells. Previously, the ability of
HNE to stimulate a transcriptional response was exam-
ined in macrophage-like cells [12]. It was observed that
HNE significantly impacted a wide range of steady-state
responses (e.g., macrophage activation, immune and
inflammatory responses, NF-κB signal transduction, ECM
degradation, and dyserythropoiesis). Comparison of the
number of gene expression changes influenced by 15-
HETE and HNE indicates that 15-HETE modulates a
number of mRNA targets but is a much less potent agent
than HNE (Figure 3).
IPA was also used to perform a functional analysis on
genes within the entire data set. Comparison of the bio-
logical functions modulated by 15-HETE (Table 1) and
HNE [12] revealed that 15-HETE affected a considerably
smaller group of transcripts than HNE but mediated a
comparable response in terms of the number of molecular
and cellular functions and the specific categories affected.
Both lipid peroxidation products altered "Cell Cycle",
"Cell Morphology", "Cellular Assembly and Organiza-
tion", "Cell Death", "Cellular Development", "Cell
Growth and Proliferation", "Gene Expression", and
"Small Molecule Biochemistry". 15-HETE affected several
unique categories including "Carbohydrate Metabolism",
"Drug Metabolism", "Lipid Metabolism", "Molecular
Transport", "RNA Damage and Repair", and "RNA Post-
Translational Modification".
Both IPA network and functional analyses identified a
large group of "lipid metabolism" and "carbohydrate
metabolism" expression changes. Given that Il1b  acts
upstream of Cyp3a4, Ugdh, Gnas, Gm2a, Psen1, and Il15,
stimulated Il1b expression may be indirectly involved in
the up-regulation of each of these genes in this study.
Expression of several "small molecule biochemistry" tran-
scriptional regulators (Bclaf1, Med1, Rnf4, Noc2l, and
Zfp36l1) was also identified.
Differential gene expression in the context of malaria 
pathogenesis
Differentially expressed genes were sorted into lists based
on the direction of regulation, and corresponding Gene
Ontology (GO) categories were identified. Gene expres-
sion alterations mediated by 15-HETE were compared to
two groups of transcripts. The first group consisted of spe-
cific genes or gene products associated with human [16]
or murine [17,18] models of malarial infection or Hz
exposure [19]. Common transcripts were primarily associ-
ated with "cell-to-cell signaling and interaction" and
"immune response" (e.g., Fcgrt,  Cd86,  C5ar1,  Ccr4,
Mapk14, Pik3ap1, Tapbp, and Tnfaip6). Enhanced expres-
sion of guanylate nucleotide binding proteins (Gbp) 1 and
3 observed in this study was consistent with expression
changes reported in human and experimental murine
malaria [16-18,20]. The second group included genes
classified under specific GO processes that are overex-
pressed in the Plasmodium yoelii model [20] and/or natu-
rally acquired Plasmodium falciparum infections [21],
including cell-cell signaling, defense response, immune
response, inflammatory response, and signal transduc-
tion, among others. Differential expression mediated by
15-HETE treatment that correlated with either of the two
Comparison of differentially expressed genes mediated by  15-HETE and HNE Figure 3
Comparison of differentially expressed genes medi-
ated by 15-HETE and HNE. Data sets for each treatment 
group (15-HETE or HNE) were generated from statistically 
significant (p ≤ 0.025) transcripts up- or down-regulated ≥ 
1.8-fold in 2 of 3 samples relative to untreated LPS-stimu-
lated cells. Venn diagrams show intersections of the resulting 
15-HETE and HNE data subsets. (A) Decreased and (B) 
increased expression are shown separately.
Table 1: Functional Analysis of 15-S-HETE Data Seta
Biological Function p value
carbohydrate metabolism 6.42 ×10-6
cell cycle 1.28 × 10-4
cell death 1.93 × 10-5
cell morphology 2.53 × 10-4
cellular assembly and organization 5.30 × 10-4
cellular compromise 4.52 × 10-4
cellular development 3.42 × 10-5
cellular growth and proliferation 3.81 × 10-4
drug metabolism 3.81 × 10-4
gene expression 2.22 × 10-4
lipid metabolism 1.25 × 10-3
molecular transport 3.81 × 10-4
RNA damage and repair 3.79 × 10-4
RNA post-transcriptional modification 3.79 × 10-4
small molecule biochemistry 3.81 × 10-4
a Ingenuity Pathway Analysis uses a right-tailed Fisher exact test to 
calculate p values. Significance values for each data set indicate the 
probability that the association between the genes and the given 
biological function is due to random chance.Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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groups described above is listed in Table 2. The relatively
limited correlation reflects differences between 15-HETE-
mediated expression changes in this model and expres-
sion changes observed during naturally acquired or exper-
imental malaria. While RAW 264.7 cells have previously
been shown to mimic monocyte/macrophage immuno-
modulation in the presence of HNE [12], the findings pre-
sented herein suggest that 15-HETE is not a major contrib-
utor to the altered immune response observed in these
cells types during infection.
Validation of microarray results
qRT-PCR was used to confirm several genes susceptible to
differential regulation by 15-HETE. The analysis focused
on selected genes implicated in the host response to
malaria. The results shown in Figure 4 are expressed as
fold change relative to LPS-stimulated cells. In agreement
with the microarray results in terms of magnitude and
direction of change, 15-HETE stimulated the expression of
Arf3  (ADP-ribosylation factor 3), Cldn11  (claudin 11),
Cxcl11  (chemokine (C-X-C motif) ligand 11), Mapk14
(mitogen-activated protein kinase 14), Prdx1 (peroxire-
doxin 1), and Sdc1 (syndecan 1) and repressed the expres-
sion of Egr1 (early growth response 1).
Discussion
Global responses to malaria infection have been exam-
ined at the molecular level in the blood of human victims
[16,21], malaria positive tissue [22], and both murine
[17,18,20] and monkey [23] malaria models using micro-
array technology. Perturbations of gene expression associ-
ated with erythropoiesis, glycolysis, metabolism, B-cell
activation, and inflammation were frequently identified
in these analyses; however, the specific agents responsible
for mediating expression changes remain unknown. Accu-
mulating evidence supports the hypothesis that many of
the adverse effects of malaria are not caused directly by the
parasite, but by endogenous toxins generated during
interactions with parasite-derived species such as Hz [24].
The immuno-modulatory response to native Hz has been
recapitulated using individual components of Hz (i.e.,
membrane lipids from erythrocyte ghosts incubated with
BH) in a model system [13]. Macrophage-like cells treated
with the reaction supernatant exhibited a dose-dependent
impairment of PMA-activated NADPH oxidase and LPS-
stimulated iNOS activities. Neither BH- nor ghost-super-
natant alone altered NADPH or iNOS activity, indicating
that lipid peroxidation products generated during reac-
tions between BH and ghost membranes were responsible
for the inhibitory effects. Several laboratories have shown
that biologically relevant levels of the individual lipid per-
oxidation products HNE and 15-HETE were capable of
mimicking the dysfunctional response to Hz phagocyto-
sis, suggesting the basis of Hz activity [13,25,26].
Considering these results, global responses to individual
Hz constituents are of particular interest. The ability of
specific and nonspecific malaria toxins to stimulate
changes in gene expression has recently been examined in
macrophage-like cells [12]. Microarray analyses of two
individual Hz components (i.e., BH and HNE) indicated
that while BH primarily elicited a phagocytic response,
HNE significantly perturbed a myriad of biological proc-
esses. These results substantiated further exploration of a
potential role for the Hz-associated lipid peroxidation
product 15-HETE.
In the current study, activated RAW 264.7 macrophage-
like cells were treated with 15-HETE, and mRNA levels
were assessed at 24 h to mimic a steady-state response that
would be relevant to an established malaria infection. IPA
software was utilized to perform complementary network
(Figure 2) and functional (Table 1) analyses for identifica-
tion of biological relationships within the data. Figure 3
shows that the number of expression changes mediated by
15-HETE was modest relative to the previously reported
global response to HNE [12]. Unlike the mode of action
behind HNE's biological activity (forming adducts to cel-
lular nucleophiles and subsequently modulating intracel-
lular signaling), 15-HETE serves as a ligand for the nuclear
PPARγ receptor [27]. As expected, downstream PPARγ sig-
naling transcripts (e.g., Adfp, Ca2, Cyp3a4, M6pr, M6prbp1,
Med1, Med7, and Sdc1) were elevated in response to 15-
HETE.
Cytoadherence
A balance between removal of Plasmodium from circula-
tion and sequestration inside host cells is crucial for para-
site survival during infection. Sequestration is mediated
by cytoadherence, specifically, the adherence of parasit-
ized RBCs (PRBCs) and leukocytes to capillary and post-
capillary venular endothelial cells (EC). This cytoadher-
ence reduces blood flow and causes metabolic dysfunc-
tion [28] and is thought to be a major factor associated
with cerebral malaria (CM). The mechanism(s) used for
adhesion and migration involve the expression of consti-
tutive ligands (i.e., adhesion molecules) and receptors on
PRBCs or leukocytes and EC. Cell-cell and cell-matrix
interactions are also mediated by the secretion of micro-
bial products or cytokines, which enhance the expression
of inducible adhesion molecules.
Investigation of potential arachidonic acid metabolite
involvement in cytoadherence identified 15-HETE as an
agent capable of stimulating basal adhesion of erythro-
cytes [15] and monocytes to EC [29,30]. In this study, 15-
HETE induced the expression of several transcripts
involved in integrin signaling (e.g., Crkl, Rap2b, Arf3). The
expression of genes encoding Pkd2 and Sdc1, which are
involved in cell-cell and cell-matrix interactions, andMalaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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Table 2: Select Gene Expression Changes Mediated by 15-HETEa
Gene Symbol Fold Change Probe ID Description Entrez ID Ref
Electron Transport [21]
Cyp3a11 3.6 516253 Cytochrome P450, family 3, subfamily a, polypeptide 11 13112
Smox 5.1 560410 Spermine oxidase 228608
Ugdh 1.9 500013 UDP-glucose dehydrogenase 22235
Regulation of Transcription, DNA-Dependent [21]
Bclaf1 -1.9 549609 BCL2-associated transcription factor 1 72567
Cdk9 2.1 392872 Cyclin-dependent kinase 9 (CDC2-related kinase) 107951
Creg1 1.9 760346 Cellular repressor of E1A-stimulated genes 1 433375
Egr1 -4.7 524988 Early growth response 1 13653
Fbxl11 -2.9 464056 F-box and leucine-rich repeat protein 11 225876
Fli1 2.3 407869 Friend leukemia integration 1 14247
Fliih 4.6 706377 Flightless I homologue (Drosophila)1 4 2 4 8
Hlx1 2.1 915372 H2.0-like homeo box 1 (Drosophila)1 5 2 8 4
Mxd1 2.1 520449 MAX dimerization protein 1 17119
Myst2 5.4 494053 MYST histone acetyltransferase 2 217127
Pou2f2 -4.4 911620 POU domain, class 2, transcription factor 2 18987
Pparbp 1.9 553770 Peroxisome proliferator activated receptor binding protein 19014
Pspc1 2.0 474771 Paraspeckle protein 1 66645
Rab11a 2.0 359489 RAB11a, member RAS oncogene family 53869
Rnf4 2.5 567180 Ring finger protein 4 19822
Tsc22d3 2.0 700170 TSC22 domain family 3 14605
Zfp482 2.0 435236 Zinc finger protein 482 241322
Protein Biosynthesis [20,21]
Eprs 4.9 455664 Glutamyl-prolyl-tRNA synthetase 107508
Protein Folding [21]
Clpx 2.4 733670 Caseinolytic peptidase X (E. coli)2 7 0 1 6 6
Hspa4 3.5 578003 Heat shock protein 4 15525
Ubiquitin Cycle [21]
Cul7 0.4 742757 Cullin 7 66515
Fbxo3 1.9 832607 F-box only protein 3 57443
Ube2l6 2.0 401185 Ubiquitin-conjugating enzyme E2L 6 56791 [16]
Intracellular Protein Transport [21]
Ap1s2 2.0 605927 Adaptor-related protein complex 1, sigma 2 subunit 108012
Arf3 4.4 652348 ADP-ribosylation factor 3 11842
Sort1 2.4 339169 Sortilin 1 20661
Response to Stress [21]
Mapk14 2.2 755610 Mitogen activated protein kinase 14 26416 [16]
Prdx1 2.1 530413 Peroxiredoxin 1 18477 [17]
Prdx6 -2.0 825043 Peroxiredoxin 6 11758
Defense Response [20,21]
Bst1 2.1 837914 Bone marrow stromal cell antigen 1 12182
Klra18 2.5 806675 Killer cell lectin-like receptor, subfamily A, member 18 93970
Tapbp 2.0 928057 TAP binding protein 21356 [20]Malaria Journal 2009, 8:195 http://www.malariajournal.com/content/8/1/195
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Inflammatory Response [20,21]
Abcb1a 2.6 677412 ATP binding cassette, sub-family B (MDR/TAP), member 1A 97570
Ca2 4.0 574832 Carbonic anhydrase 2 88269
Card12 2.2 336709 Caspase recruitment domain family, member 12 268973
Cdkn1b 3.7 516253 Cytochrome P450, family 3, subfamily a, polypeptide 11 104565
Clu 4.0 379462 Clusterin 88423
Cr1l 1.9 538208 Complement component (3b/4b) receptor 1-like 88513
Cyp3a11 3.7 516253 Cytochrome P450, family 3, subfamily a, polypeptide 11 88609
Fyn 2.50 766362 Fyn proto-oncogene 95602
H2-Q8 1.8 712519 Histocompatibility 2, Q region locus 8 95937
Hnrnpa3 4.8 903894 Heterogeneous nuclear ribonucleoprotein A3 1917171
Mrc1 2.9 331550 Mannose receptor, C type 1 97142
Pole4 2.3 508321 Polymerase (DNA-directed), ε 4 (p12 subunit) 1914229
Ppp3r1 2.7 716541 Protein phospatase 3, regulatory subunit B, α isoform (calcineurin B, type I) 107172
Procr 2.0 431405 Protein C receptor, endothelial 104596
Rrm1 5.6 865694 Ribonucleotide reductase M1 98180
Serpinb2 4.0 860577 Serine (or cysteine) proteinase inhibitor, clade B, member 2 97609
Leukocyte Extravasation and Signalling
Arhgap12 2.2 465731 ρ GTPase activating protein 12 1922665
Crkl 3.0 389169 V-crk sarcoma virus CT10 oncogene homologue (avian)-like 104686
Ptk2b 2.6 867483 PTK2 protein tyrosine kinase 2 β 104908
Immune Response [20,21]
Cxcl11 5.1 921243 Chemokine (C-X-C motif) ligand 11 56066
Ddx58 7.1 438990 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 230073
Fcgrt 2.0 390657 Fc receptor, IgG, α chain transporter 14132 [16]
Gbp1 2.9 586296 Guanylate nucleotide binding protein 1 14468 [16,18,20
]
Gbp3 3.0 405120 Guanylate nucleotide binding protein 3 55932 [17,20]
Ifit3 3.2 888038 Interferon-induced protein with tetratricopeptide repeats 3 15959
Il1a 5.1 595893 Interleukin 1 α 96542
Il1b 2.4 734612 Interleukin 1 β 16176
Il15 1.9 876196 Interleukin 15 16168
Cell Cycle [20]
Ccnf 2.4 767163 Cyclin F 12449
Cdkn1b 3.7 704876 Cyclin-dependent kinase inhibitor 1B (P27) 12576
Pmp22 1.9 616997 Peripheral myelin protein 18858
Rhob -2.2 925472 Ras homologue gene family, member B 11852
Cell Adhesion [21]
Cldn11 4.9 338333 Claudin 11 18417
Scarb2 2.5 561450 Scavenger receptor class B, member 2 12492
Tnfaip6 1.9 614886 Tumor necrosis factor alpha induced protein 6 21930 [16]
Signal Transduction [20]
Ccr4 2.2 618105 Chemokine (C-C motif) receptor 4 12773 [18]
Cd86 3.2 908805 Cd86 antigen 12524 [20,22]
Gnas 1.8 646267 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus 14683
Ms4a4c 2.8 791872
495283
Membrane-spanning 4-domains, subfamily A, member 4C 64380
Olfr472 -2.2 591718 Olfactory receptor 472 258770
Prkrir 3.4 561755 Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, 
repressor of (P58 repressor)
72981
Ptger2 3.0 912597 Prostaglandin E receptor 2 (subtype EP2) 19217
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Rin1 -1.9 478326 Ras and Rab interactor 1 225870
Ywhag 4.1 606287 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma 
polypeptide
22628
G-Protein Coupled Receptor Protein Signaling Pathway [21]
Olfr1303 -2.0 366625 Olfactory receptor 1303 258397
Olfr316 -1.9 903210 Olfactory receptor 316 258064
Olfr435 -3.2 810459 Olfactory receptor 435 258647
Slc19a2 1.9 763767 Solute carrier family 19 (thiamine transporter), member 2 116914
Cell-Cell Signaling [21]
Wnt6 2.0 590115 Wingless-related MMTV integration site 6 22420
Development [21]
Egfl4 -2.2 914308 EGF-like-domain, multiple 4 269878
Lrp6 -2.3 691244 Low density lipoprotein receptor-related protein 6 16974
Pgf 2.9 932795 Placental growth factor 18654
Metabolism [20]
Atp1a2 2.1 684165 ATPase, Na+/K+ transporting, α 2 polypeptide 98660
Atp2c1 2.0 388850 ATPase, Ca2+ sequestering 235574
Echdc3 2.2 331450 Enoyl Coenzyme A hydratase domain containing 3 67856
Hsd17b4 2.2 303973 Hydroxysteroid (17-beta) dehydrogenase 4 15488
Mmp9 -12.3 710293 Matrix metalloproteinase 9 17395
Oas3 -3.0 487213 2'-5' oligoadenylate synthetase 3 246727 [16]
Carbohydrate Transport [21]
Slc35a4 2.5 318829 Solute carrier family 35, member A4 67843
Protein Transport [21]
Exoc2 3.0 498825 Exocyst complex component 2 66482
Nupl2 2.1 868036 Nucleoporin like 2 231042
Rab20 2.0 410549 RAB20, member RAS oncogene family 19332
Rap2b 2.2 471908 RAP2B, member of RAS oncogene family 74012
Rheb 1.9 653270 RAS-homologue enriched in brain 19744
Zfyve20 2.9 669220 Zinc finger, FYVE domain containing 20 78287
Protein Ubiquitination [21]
Trim12 2.7 454451 Tripartite motif protein 12 76681
Trim34 2.9 600486 Tripartite motif protein 34 94094
Differentiation [21]
Ndrg2 2.1 468211 N-myc downstream regulated gene 2 29811
Other
Pik3ap1 2.0 646764 Phosphoinositide-3-kinase adaptor protein 1 83490 [16]
a Transcripts altered ≥ 1.8-fold (p ≤ 0.025) in 15(S)-HETE-treated RAW 264.7 cells that are associated with specific genes or gene products 
correlated to malaria (referenced in column 6) or genes that are classified with specific over-expressed GO biological processes in malaria models 
(referenced with biological process heading), are shown in the table. Fold changes (FC) represent the average of three independent biological 
experiments. Bold FC indicate that multiple probes gave analogous results (average FC is shown).
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Ptpn14, which has alleged involvement in cell adhesion,
were also induced by 15-HETE.
Leukocyte extravasation and chemotaxis
The inflammatory response to malaria, both acute and
chronic, follows a predictable sequence of events. Initial
vascular changes precede increases in permeability, which
ultimately causes oedema. Enhanced cytoadherence
results in the accumulation, adherence, and migration of
leukocytes through vascular endothelium. Molecular
mediators are subsequently released and contribute to
both the immune response and recruitment/activation of
effector cells. Overwhelming evidence demonstrates that
the pathophysiology of malaria involves both systemic
and local cytokine release. The recruitment of phagocytes
around cerebral capillaries has been observed in CM and
likely explains increased chemotaxis and chemokinesis
[31]. CM is a severe complication of P. falciparum infec-
tion that is characterized by cytoadherence in cerebral
microvasculature. Accumulation of Hz-loaded monocytes
has been observed in brains of CM victims [32] and may
contribute to the disruption of endothelial basement
membrane and subsequent extravasation of blood cells
[26]. Importantly, blood brain barrier (BBB) destruction
and enhanced vascular permeability/oedema are major
factors associated with CM [33,34].
A potential contribution of 15-HETE toward increased
vascular permeability has been examined in the lung.
Administration of this hydroxylated fatty acid was shown
to increase respiratory oedema fluid production [35], sug-
gesting a role as an inflammatory mediator. The current
analysis identified the "Leukocyte Extravasation Signal-
ing" pathway as being significantly (p = 0.015) affected by
15-HETE. Specifically, the steady-state expression of
Arhgap12, Cldn11, Crkl, Mapk14, and Ptk2b was up-regu-
lated. Although 15-HETE is generally considered to have
anti-inflammatory properties, activation of a large group
of genes encoding inflammatory response molecules was
observed (Table 2).
15-HETE and MMP9 Regulation
15-HETE was recently shown to enhance IL1β expression
and MMP9 activity in human monocytes [26]. The current
study identified a different response to 15-HETE. While
Il1b mRNA was elevated in 15-HETE treated LPS-stimu-
lated RAW 264.7 cells, Mmp9 mRNA was down-regulated
(-4.8-fold by qRT-PCR). Mmp9 expression can be regu-
lated through a variety of signaling cascades including NF-
κB, p38 MAPK, and ERK1/2 pathways [36]. It was pro-
posed that enhanced regulation of IL1B and MMP9 by 15-
HETE in human monocytes may be associated with NF-κB
signaling [26] based on reports demonstrating NF-κB-
mediated MMP9 expression in LPS-stimulated RAW 264.7
cells [36]. This mechanism seems unlikely given that 15-
HETE has been shown to impair NF-κB-mediated expres-
sion of iNOS in LPS-stimulated RAW 264.7 cells [13]. Fur-
thermore, PPARγ ligands have been shown to repress NF-
κB signal transduction [37,38] and inhibit MMP9 expres-
sion, secretion, and activity in macrophages and vascular
smooth muscle cells [39-41], in accord with the results of
this study.
Conclusion
The complex innate and adaptive host immune responses
to malaria are triggered by the presence of P. falciparum
parasites, composite native Hz, Hz-derived lipid peroxida-
tion products, and other cellular debris. A reductionist
examination of the cellular response to two individual
constituents of native Hz, BH and HNE [12], implicated a
significant role for lipid peroxidation products in macro-
phage immuno-modulation. Consequently, the global
response of macrophage-like cells to 15-HETE was
explored. 15-HETE has previously been implicated as hav-
ing a functional role in a variety of cellular processes such
as inflammation, asthma, carcinogenesis, and atheroscle-
rosis.15-HETE can be incorporated into membrane lipids
and alter both vascular tone and EC permeability [14],
Quantitative real-time RT-PCR validation of microarray  results Figure 4
Quantitative real-time RT-PCR validation of micro-
array results. RAW 264.7 cells were stimulated with 0.1 
μg/mL LPS and treated with 40 μM 15-HETE for 24 h prior 
to RNA extraction. Fold-changes (treated stimulated cells 
relative to stimulated cells) are shown (  ± 99% confidence 
interval for quadruplicate measurements of n = 3 biological 
replicates). Abbreviations: Arf3 (ADP-ribosylation factor 3), 
Cldn11 (claudin 11), Cxcl11 (chemokine (C-X-C motif) ligand 
11), Egr1 (early growth response 1), Mapk14 (mitogen-acti-
vated protein kinase 14), Prdx1 (peroxiredoxin 1), and Sdc1 
(syndecan 1).
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supporting a potential role in malaria pathogenesis as
well. In the current study, the response to 15-HETE was
significantly associated with altered expression of "lipid
metabolism" and "small molecule biochemistry" genes.
Several genes related to "cytoadherence", "leukocyte
extravasation", and "inflammatory response" were also
differentially regulated by 15-HETE treatment. While
these change uphold a potential role for 15-HETE in
malaria pathogenesis, the small number of expression
changes indicates that 15-HETE does not elicit a major
response from macrophage-like cells in this model. These
results add insight and detail to 15-HETE's effect on gene
expression in macrophage-like cells, but there are limita-
tions to any model system. For example, 15-HETE repre-
sents but one structural HETE isomer that is associated
with Hz; 5-, 8-, 9-, 11-, and 12-HETE have also been iden-
tified [13,42]. 5- and 15-HETE are reported to be the pre-
dominant isomers formed during iron catalyzed or Hz-
mediated oxidation of AA [42,43], yet 12-HETE may exert
greater biological activity [13]. Current findings suggest
that upon phagocytosis, the sum of all species adsorbed to
the surface of Hz likely mediate a synergistic immuno-
modulatory response. Future studies will address expres-
sion changes in primary human monocytes and macro-
phages in response to native Hz and Hz-associated lipid
peroxidation products.
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